{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:31:48Z","timestamp":1786375908269,"version":"build-2736575974"},"reference-count":56,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Amyotrophic lateral sclerosis (ALS), the most common type of motor neurone disease (MND), is a devastating diagnosis that often leads to mortality within 2\u20135 years of symptom onset. Respiratory failure and aspiration pneumonia both associated with respiratory muscle weakness are the most common causes of death. Difficult to diagnose and devastating in its prognosis, much research has aimed to identify a reliable biomarker to diagnose ALS, prognosticate and improve enrolment into clinical trials to further research efforts. Over the last few decades, neurofilaments (NFs) have emerged as promising biomarkers, especially neurofilament light chain (NFL) and phosphorylated neurofilament heavy chain (pNFH). This review aims to summarise the current evidence for use of NFs as biomarkers in ALS. Current Evidence: Higher levels of NFL and pNFH are measured in CSF than in serum, and levels in CSF and serum are correlated. High CSF NFL, serum NFL and CSF pNFH levels could differentiate patients with ALS from healthy controls, other neurological disease, neurodegenerative controls (without MND), other MND subtypes and ALS disease mimics; however, studies reported a high degree of heterogeneity irrespective of which media or NFs have been used. The number of studies examining NFs to predict respiratory failure in patients with ALS is low. Conclusions and Future Directions: Despite numerous studies consistently reporting higher NF levels in ALS compared to various controls, their clinical value is limited due to high heterogeneity of the results and inconsistencies in proving its prognostic value. Further understanding the relationship between NF levels and respiratory failure is paramount to improve the quality of life of patients with ALS and increase survival.<\/jats:p>","DOI":"10.3390\/jcm15166196","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:10:24Z","timestamp":1786374624000},"page":"6196","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Neurofilaments in Diagnosis and Monitoring of Amyotrophic Lateral Sclerosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0089-2122","authenticated-orcid":false,"given":"Anwen","family":"Davies","sequence":"first","affiliation":[{"name":"School of Medical Sciences, University of Manchester, Manchester M14 4PX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bentley","sequence":"additional","affiliation":[{"name":"Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK"},{"name":"Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M14 4PX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-740X","authenticated-orcid":false,"given":"Andras","family":"Bikov","sequence":"additional","affiliation":[{"name":"Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK"},{"name":"Division of Infection, Immunity & Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M14 4PX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/pmj.78.923.513","article-title":"Motor neurone disease","volume":"78","author":"Talbot","year":"2002","journal-title":"Postgrad. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0141076813511451","article-title":"Advances in motor neurone disease","volume":"107","author":"Talbot","year":"2014","journal-title":"J. R. Soc. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.clinph.2009.02.170","article-title":"Predicting respiratory insufficiency in amyotrophic lateral sclerosis: The role of phrenic nerve studies","volume":"120","author":"Pinto","year":"2009","journal-title":"Clin. Neurophysiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rizea, R.E., Corlatescu, A.-D., Costin, H.P., Dumitru, A., and Ciurea, A.V. (2024). Understanding Amyotrophic Lateral Sclerosis: Pathophysiology, Diagnosis, and Therapeutic Advances. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189966"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_8","first-page":"e802","article-title":"ALS phenotype is influenced by age, sex, and genetics: A population-based study","volume":"94","author":"Moglia","year":"2020","journal-title":"Neurology"},{"key":"ref_9","first-page":"181","article-title":"Risk factors for amyotrophic lateral sclerosis","volume":"7","author":"Ingre","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/21678421.2022.2059380","article-title":"Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017","volume":"24","author":"Mehta","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s10072-023-06718-8","article-title":"Environmental and Occupational solvents exposure and amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"44","author":"Zhang","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjsports-2023-106890","article-title":"Examining later-in-life health risks associated with sport-related concussion and repetitive head impacts: A systematic review of case-control and cohort studies","volume":"57","author":"Iverson","year":"2023","journal-title":"Br. J. Sports Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Alanazi, N., Fitzgerald, M., Hume, P., Hellewell, S., Horncastle, A., Anyaegbu, C., Papini, M.G., Hargreaves, N., Halicki, M., and Entwistle, I. (2024). Concussion-Related Biomarker Variations in Retired Rugby Players and Implications for Neurodegenerative Disease Risk: The UK Rugby Health Study. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147811"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/21678421.2023.2189911","article-title":"Association of the practice of contact sports with the development of amyotrophic lateral sclerosis","volume":"24","author":"Henriques","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"88","author":"Zou","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e16371","DOI":"10.1111\/ene.16371","article-title":"Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta-analysis","volume":"31","author":"Verde","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shahim, P., Norato, G., Sinaii, N., Zetterberg, H., Blennow, K., Chan, L., and Grunseich, C. (2024). Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Genes, 15.","DOI":"10.3390\/genes15040496"},{"key":"ref_18","first-page":"85","article-title":"Amyotrophic lateral sclerosis mimic syndromes","volume":"15","author":"Ghasemi","year":"2016","journal-title":"Iran. J. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"117054","DOI":"10.1016\/j.jns.2020.117054","article-title":"Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis","volume":"417","author":"Richards","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1186\/s12967-024-05767-7","article-title":"CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"22","author":"Agah","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Verber, N.S., Shepheard, S.R., Sassani, M., McDonough, H.E., Moore, S.A., Alix, J.J.P., Wilkinson, I.D., Jenkins, T.M., and Shaw, P.J. (2019). Biomarkers in Motor Neuron Disease: A State of the Art Review. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00291"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"Respiratory Failure in Amyotrophic Lateral Sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/21678421.2025.2471421","article-title":"Respiratory measurements, respiratory symptoms, and quality of life in ALS: Results from the REVEALS study","volume":"26","author":"Murray","year":"2025","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpainsymman.2020.02.021","article-title":"Dyspnea as a Fatigue-Promoting Factor in ALS and the Role of Objective Indicators of Respiratory Impairment","volume":"60","author":"Vogt","year":"2020","journal-title":"J. Pain Symptom Manag."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/jnnp-2021-327968","article-title":"Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants","volume":"93","author":"Chio","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/21678421.2021.1908362","article-title":"Correlations between measures of ALS respiratory function: Is there an alternative to FVC?","volume":"22","author":"Murray","year":"2021","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1212\/WNL.0000000000200758","article-title":"Comparative Performance of Different Respiratory Test Parameters for Detection of Early Respiratory Insufficiency in Patients With ALS","volume":"99","author":"Kelly","year":"2022","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/21678421.2024.2359556","article-title":"REVEALS-a longitudinal cohort study of multifaceted respiratory assessment in ALS","volume":"25","author":"Rooney","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Manera, U., Torrieri, M.C., Moglia, C., Canosa, A., Vasta, R., Palumbo, F., Matteoni, E., Cabras, S., Grassano, M., and Bombaci, A. (2024). Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS). Brain Sci., 14.","DOI":"10.3390\/brainsci14020157"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4155\/cli.14.52","article-title":"Outcome measures in amyotrophic lateral sclerosis clinical trials","volume":"4","author":"Paganoni","year":"2014","journal-title":"Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and Neurofilament Proteins in Health and Disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.conb.2020.02.001","article-title":"Neurofilaments in disease: What do we know?","volume":"61","author":"Gordon","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014Towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_37","unstructured":"Cooper, G.M. (2025, February 09). Intermediate Filaments, The Cell: A Molecular Approach, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK9834\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.tcb.2020.06.004","article-title":"Cytoskeletal Crosstalk in Cell Migration","volume":"30","author":"Seetharaman","year":"2020","journal-title":"Trends Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"fcae288","DOI":"10.1093\/braincomms\/fcae288","article-title":"Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis","volume":"6","author":"Vidovic","year":"2024","journal-title":"Brain Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1152\/jn.00398.2021","article-title":"Phosphorylated neurofilament heavy chain: A potential diagnostic biomarker in amyotrophic lateral sclerosis","volume":"127","author":"Heckler","year":"2022","journal-title":"J. Neurophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/21678421.2021.2007952","article-title":"Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: A meta-analysis study","volume":"23","author":"Sferruzza","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Xu, Z., Henderson, R.D., David, M., and McCombe, P.A. (2016). Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164625"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/21678421.2022.2119868","article-title":"Combination of ciprofloxacin\/celecoxib as a novel therapeutic strategy for ALS","volume":"24","author":"Pushett","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/s41467-023-40734-8","article-title":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis","volume":"14","author":"Mandrioli","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/21678421.2024.2423707","article-title":"Plasma neurofilament analysis in VITALITY-ALS","volume":"26","author":"Simkins","year":"2025","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/acn3.52126","article-title":"Cardiac Troponin T as a Serum Biomarker of Respiratory Impairment in Amyotrophic Lateral Sclerosis","volume":"11","author":"Koch","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e14164","DOI":"10.1111\/jsr.14164","article-title":"Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance","volume":"33","author":"Sehr","year":"2024","journal-title":"J. Sleep Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Verde, F., Milone, I., Colombo, E., Maranzano, A., Solca, F., Torre, S., Doretti, A., Gentile, F., Manini, A., and Bonetti, R. (2023). Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1132808"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/bio.16.17","article-title":"Development of an ultra-sensitive Simoa assay to enable GDF11 detection: A comparison across bioanalytical platforms","volume":"8","author":"Myzithras","year":"2016","journal-title":"Bioanalysis"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Alster, P., Madetko, N., Koziorowski, D., and Friedman, A. (2020). Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP). Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00893"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6196\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:21:42Z","timestamp":1786375302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":56,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166196"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166196","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}